{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T05:08:19Z","timestamp":1782623299859,"version":"3.54.5"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003785","name":"Guangdong Provincial Medical Research Foundation","doi-asserted-by":"publisher","award":["B2025227"],"award-info":[{"award-number":["B2025227"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Science and Technology Program Key Projects","doi-asserted-by":"publisher","award":["2023B03J1291"],"award-info":[{"award-number":["2023B03J1291"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100064"],"award-info":[{"award-number":["82100064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2023ZD0506900"],"award-info":[{"award-number":["2023ZD0506900"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117366","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:27:29Z","timestamp":1758734849000},"page":"117366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P3","title":["Chronic inhibition of cGMP-specific phosphodiesterase 5 attenuates myocardial hypertrophy by promoting mitophagy in cardiomyocytes"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2350-7536","authenticated-orcid":false,"given":"Xuedi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeding","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenggang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan Zijian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunping","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.bcp.2025.117366_b0005","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.5469","article-title":"The leading Causes of death in the US for 2020","volume":"325","author":"Ahmad","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.bcp.2025.117366_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-022-00806-6","article-title":"Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential","volume":"20","author":"Martin","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117366_b0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-023-00887-x","article-title":"Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges","volume":"20","author":"Ritterhoff","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bcp.2025.117366_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052667","article-title":"Mitochondrial Dysfunction in Heart failure: from Pathophysiological Mechanisms to Therapeutic Opportunities","author":"Gallo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117366_b0025","article-title":"Exploratory bibliometric analysis and text mining to reveal research trends in cardiac aging","volume":"7","author":"Kamihara","year":"2024","journal-title":"Aging Med (milton)"},{"issue":"9","key":"10.1016\/j.bcp.2025.117366_b0030","first-page":"5908","article-title":"CD47 antibody suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy","volume":"12","author":"Li","year":"2020","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117366_b0035","first-page":"N","article-title":"2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis","volume":"9","author":"Peng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.117366_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103563","article-title":"PDE4D inhibition ameliorates cardiac hypertrophy and heart failure by activating mitophagy","volume":"81","author":"Fu","year":"2025","journal-title":"Redox Biol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117366_b0045","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.117.312317","article-title":"AMPK\u03b12 Protects against the Development of Heart failure by Enhancing Mitophagy via PINK1 Phosphorylation","volume":"122","author":"Wang","year":"2018","journal-title":"Circ. Res."},{"issue":"16","key":"10.1016\/j.bcp.2025.117366_b0050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.123.064489","article-title":"FARS2 Deficiency Causes Cardiomyopathy by Disrupting Mitochondrial Homeostasis and the Mitochondrial Quality Control System","volume":"149","author":"Li","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2025.117366_b0055","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvae238","article-title":"PINK1-mediated mitophagy attenuates pathological cardiac hypertrophy by suppressing the mtDNA release-activated cGAS-STING pathway","volume":"121","author":"Zhou","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2025.117366_b0060","doi-asserted-by":"crossref","unstructured":"Ravindran, R. and B. Gustafsson \u00c5, Mitochondrial quality control in cardiomyocytes: safeguarding the heart against disease and ageing. Nat Rev Cardiol, 2025.http:\/\/dx.doi.org\/10.1038\/s41569-025-01142-1.","DOI":"10.1038\/s41569-025-01142-1"},{"issue":"23","key":"10.1016\/j.bcp.2025.117366_b0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1106291108","article-title":"PTEN-inducible kinase 1 (PINK1)\/Park6 is indispensable for normal heart function","volume":"108","author":"Billia","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.bcp.2025.117366_b0070","doi-asserted-by":"crossref","DOI":"10.1080\/15548627.2017.1325062","article-title":"Exercise reestablishes autophagic flux and mitochondrial quality control in heart failure","volume":"13","author":"Campos","year":"2017","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.bcp.2025.117366_b0075","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.116.303356","article-title":"Endogenous Drp1 mediates mitochondrial autophagy and protects the heart against energy stress","volume":"116","author":"Ikeda","year":"2015","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.bcp.2025.117366_b0080","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.118.314607","article-title":"Mitophagy is Essential for Maintaining Cardiac Function during High Fat Diet-Induced Diabetic Cardiomyopathy","volume":"124","author":"Tong","year":"2019","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.bcp.2025.117366_b0085","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4222","article-title":"Cardioprotection and lifespan extension by the natural polyamine spermidine","volume":"22","author":"Eisenberg","year":"2016","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.bcp.2025.117366_b0090","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14199","article-title":"Mitophagy modulation for the treatment of cardiovascular diseases","volume":"54","author":"Forte","year":"2024","journal-title":"Eur. J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bcp.2025.117366_b0095","doi-asserted-by":"crossref","DOI":"10.1113\/JP271301","article-title":"Mitochondrial dynamics, mitophagy and cardiovascular disease","volume":"594","author":"V\u00e1squez-Trincado","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2025.117366_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2018.03.054","article-title":"PTEN induced putative kinase 1 (PINK1) alleviates angiotensin II-induced cardiac injury by ameliorating mitochondrial dysfunction","volume":"266","author":"Xiong","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bcp.2025.117366_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173724","article-title":"PDE5 inhibition improves cardiac morphology and function in SHR by reducing NHE1 activity: Repurposing Sildenafil for the treatment of hypertensive cardiac hypertrophy","volume":"891","author":"Escudero","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117366_b0110","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvn324","article-title":"Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway","volume":"81","author":"Hsu","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117366_b0115","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.99.1.168","article-title":"Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee","volume":"99","author":"Cheitlin","year":"1999","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.bcp.2025.117366_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014227","article-title":"Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II","volume":"5","author":"Mokni","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2025.117366_b0125","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.108.822072","article-title":"Ventricular phosphodiesterase-5 expression is increased in patients with advanced heart failure and contributes to adverse ventricular remodeling after myocardial infarction in mice","volume":"119","author":"Pokreisz","year":"2009","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bcp.2025.117366_b0130","doi-asserted-by":"crossref","DOI":"10.1111\/bph.12346","article-title":"Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure","volume":"170","author":"Gong","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117366_b0135","doi-asserted-by":"crossref","DOI":"10.1038\/nm1175","article-title":"Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy","volume":"11","author":"Takimoto","year":"2005","journal-title":"Nat. Med."},{"issue":"7743","key":"10.1016\/j.bcp.2025.117366_b0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-019-0895-y","article-title":"PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress","volume":"566","author":"Ranek","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2025.117366_b0145","doi-asserted-by":"crossref","DOI":"10.1002\/1873-3468.14228","article-title":"The mitochondrial regulator PGC1\u03b1 is induced by cGMP-PKG signaling and mediates the protective effects of phosphodiesterase 5 inhibition in heart failure","volume":"596","author":"Zhu","year":"2022","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2025.117366_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155717","article-title":"Qiangxinyin formula protects against isoproterenol-induced cardiac hypertrophy","volume":"130","author":"Zhou","year":"2024","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.bcp.2025.117366_b0155","doi-asserted-by":"crossref","DOI":"10.7150\/ijbs.89253","article-title":"The SIRT3-ATAD3A axis regulates MAM dynamics and mitochondrial calcium homeostasis in cardiac hypertrophy","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117366_b0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-023-01563-2","article-title":"Bellidifolin ameliorates isoprenaline-induced cardiac hypertrophy by the Nox4\/ROS signalling pathway through inhibiting BRD4","volume":"9","author":"Zhou","year":"2023","journal-title":"Cell Death Discov"},{"issue":"5","key":"10.1016\/j.bcp.2025.117366_b0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-020-0496-1","article-title":"Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes","volume":"42","author":"Liu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2025.117366_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156503","article-title":"Shenfuyixin Granules enhance mitochondrial autophagy after myocardial infarction by regulating protein deacetylation via the SIRT3\/FOXO1 signaling axis","volume":"139","author":"Li","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bcp.2025.117366_b0175","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04715-1","article-title":"WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis","volume":"21","author":"Tai","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bcp.2025.117366_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103244","article-title":"A detrimental role of endothelial S1PR2 in cardiac ischemia-reperfusion injury via modulating mitochondrial dysfunction, NLRP3 inflammasome activation, and pyroptosis","volume":"75","author":"Duan","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2025.117366_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175735","article-title":"Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1\/Stat1 signaling pathway","volume":"949","author":"Liu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117366_b0190","article-title":"CDX1 improves nicotine induced cardiac fibroblasts activation and cardiomyocyte hypertrophy by alleviating autophagic flux impairment through modulation of LAPTM4B","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117366_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102088","article-title":"Alpha-ketoglutarate ameliorates pressure overload-induced chronic cardiac dysfunction in mice","volume":"46","author":"An","year":"2021","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117366_b0200","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020104705","article-title":"Molecular mechanisms and physiological functions of mitophagy","volume":"40","author":"Onishi","year":"2021","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.bcp.2025.117366_b0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-018-0176-2","article-title":"Mechanisms of mitophagy in cellular homeostasis, physiology and pathology","volume":"20","author":"Palikaras","year":"2018","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117366_b0210","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.114.300507","article-title":"Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure","volume":"114","author":"Oka","year":"2014","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117366_b0215","article-title":"Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice","volume":"119","author":"Takimoto","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117366_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111128","article-title":"Phosphodiesterase 5 (PDE5): Structure-function regulation and therapeutic applications of inhibitors","volume":"134","author":"Ahmed","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.bcp.2025.117366_b0225","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00022.2015","article-title":"Molecular Physiology of Membrane Guanylyl Cyclase Receptors","volume":"96","author":"Kuhn","year":"2016","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2025.117366_b0230","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-024-03849-6","article-title":"Triiodo-L-thyronine (T3) downregulates Npr1 gene (coding for natriuretic peptide receptor-a) transcription in H9c2 cells: involvement of \u03b2-AR-ROS signaling","volume":"85","author":"Nagaraj","year":"2024","journal-title":"Endocrine"},{"issue":"22","key":"10.1016\/j.bcp.2025.117366_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2011.09.086","article-title":"Cyclic guanosine monophosphate signaling and phosphodiesterase-5 inhibitors in cardioprotection","volume":"59","author":"Kukreja","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2025.117366_b0240","article-title":"The pharmacology of sildenafil, a novel and selective inhibitor of phosphodiesterase (PDE) type 5","volume":"114","author":"Wallis","year":"1999","journal-title":"Nihon Yakurigaku Zasshi"},{"issue":"3","key":"10.1016\/j.bcp.2025.117366_b0245","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.109.154468","article-title":"cGMP-hydrolytic activity and its inhibition by sildenafil in normal and failing human and mouse myocardium","volume":"330","author":"Vandeput","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2025.117366_b0250","doi-asserted-by":"crossref","DOI":"10.1124\/mol.63.6.1364","article-title":"[3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP","volume":"63","author":"Corbin","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117366_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111527","article-title":"Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line","volume":"542","author":"Limoncella","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117366_b0260","doi-asserted-by":"crossref","DOI":"10.1124\/mol.66.1.144","article-title":"Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation","volume":"66","author":"Blount","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117366_b0265","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.711","article-title":"Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes","volume":"19","author":"M\u00e1ty\u00e1s","year":"2017","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.bcp.2025.117366_b0270","doi-asserted-by":"crossref","DOI":"10.1038\/sj.ijir.3900713","article-title":"The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial","volume":"13","author":"Porst","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.bcp.2025.117366_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176767","article-title":"Fenofibrate reduces cardiac remodeling by mitochondrial dynamics preservation in a renovascular model of cardiac hypertrophy","volume":"978","author":"Castiglioni","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117366_b0280","doi-asserted-by":"crossref","DOI":"10.1159\/000541569","article-title":"UCF101 Rescues against Diabetes-Evoked Cardiac Remodeling and Contractile Anomalies through AMP-Activated Protein Kinase-Mediated Induction of Mitophagy","volume":"110","author":"Zhuang","year":"2025","journal-title":"Pharmacology"},{"issue":"10","key":"10.1016\/j.bcp.2025.117366_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcb.2016.05.008","article-title":"Deciphering the Molecular Signals of PINK1\/Parkin Mitophagy","volume":"26","author":"Nguyen","year":"2016","journal-title":"Trends Cell Biol."},{"issue":"14","key":"10.1016\/j.bcp.2025.117366_b0290","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M109.080796","article-title":"Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase","volume":"285","author":"Wu","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2025.117366_b0295","first-page":"6236","article-title":"Do Wortmannin and Thalidomide induce apoptosis by autophagy inhibition in 4T1 breast cancer cells in vitro and in vivo?","volume":"13","author":"Turkoz Uluer","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117366_b0300","doi-asserted-by":"crossref","DOI":"10.1038\/s41368-020-00101-5","article-title":"Regulation of FN1 degradation by the p62\/SQSTM1-dependent autophagy-lysosome pathway in HNSCC","volume":"12","author":"Liu","year":"2020","journal-title":"Int. J. Oral Sci."},{"key":"10.1016\/j.bcp.2025.117366_b0305","article-title":"Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117366_b0310","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00198.2011","article-title":"IRAG and novel PKG targeting in the cardiovascular system","volume":"301","author":"Schlossmann","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117366_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2017.11.023","article-title":"Melatonin protects diabetic heart against ischemia-reperfusion injury, role of membrane receptor-dependent cGMP-PKG activation","volume":"1864","author":"Yu","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.bcp.2025.117366_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102702","article-title":"BNP protects against diabetic cardiomyopathy by promoting Opa1-mediated mitochondrial fusion via activating the PKG-STAT3 pathway","volume":"62","author":"Chang","year":"2023","journal-title":"Redox Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225006318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:27:10Z","timestamp":1762097230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225006318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":64,"alternative-id":["S0006295225006318"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117366","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic inhibition of cGMP-specific phosphodiesterase 5 attenuates myocardial hypertrophy by promoting mitophagy in cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117366"}}